Comments are reviewed for appropriate use of tone and language
We're no longer talking about "weight loss drugs." We're talking about treatments that simultaneously address visceral fat, liver fat, glycemic control, cardiovascular risk, sleep apnea, and joint disease
Isolated LCHAD deficiency (OMIM 609016) is most common
Nat Med 9(9):1173 Eissele R, Gke R, Willemer S et al (1992) Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man
While much of this research remains preliminary and should not be interpreted as establishing medical indications for injectable glutathione, these investigations hint at potential future applications that may expand glutathione's clinical relevance
Typical Weekly Pattern During This Phase Weight loss: 0.5-1 pound weekly on average, with occasional plateau weeks Appetite: Remains suppressed but slightly less dramatically than weeks 13-24 Energy: Stable, though some people report slight decrease from peak energy in weeks 16-24 Side effects: Minimal